[Anthralin erythema: effect of concentration, contact time, oxidation products and corticosteroids. Clinical, reflection photometry and electron microscopy studies].
A comparative study on psoriatic patients and healthy volunteers demonstrated that short-term treatment with Anthralin shows significantly less side-effects on healthy skin than long-term therapy. We could also prove that the oxidation products Chrysazin and Bianthron do not cause any irritations, and that a combined therapy with Anthralin and corticoids does not reduce the development of erythema.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000873:Anthracenes / Q000009:adverse effects*; D000875:Anthralin / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D004890:Erythema / Q000139:chemically induced*; D006801:Humans; D008854:Microscopy, Electron; D010783:Photometry / Q000379:methods; D011565:Psoriasis / Q000188:drug therapy; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000873:Anthracenes; D000875:Anthralin
Das Anthralin-Erythem: Der Einfluss von Konzentration, Kontaktzeit, Oxydationsprodukten und Kortikosteroiden. Klinische, reflektionsphotometrische und elektronen-mikroskopische Untersuchungen.